ANGIODYNAMICS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ANGIODYNAMICS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | May 31, 2021 | $291.01M | Jul 27, 2021 |
| FY2020 | May 31, 2020 | $58.33M | Aug 10, 2020 |
| FY2020 | Feb 29, 2020 | $69.78M | Aug 10, 2020 |
| FY2020 | Nov 30, 2019 | $70.00M | Aug 10, 2020 |
| FY2020 | Aug 31, 2019 | $66.04M | Aug 10, 2020 |
| FY2020 | May 31, 2019 | $71.18M | Aug 10, 2020 |
| FY2020 | Feb 28, 2019 | $65.52M | Aug 10, 2020 |
| FY2020 | Nov 30, 2018 | $69.99M | Aug 10, 2020 |
| FY2020 | Aug 31, 2018 | $63.94M | Aug 10, 2020 |
| FY2019 | May 31, 2018 | $66.19M | Jul 25, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $292.50M | Jul 18, 2025 |
| FY2025 | May 31, 2024 | $303.91M | Jul 18, 2025 |
| FY2025 | May 31, 2023 | $338.75M | Jul 18, 2025 |
| FY2024 | May 31, 2022 | $316.22M | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $291.01M | Aug 3, 2023 |
| FY2022 | May 31, 2020 | $264.16M | Jul 22, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | May 31, 2017 | $86.91M | Aug 4, 2017 |
| FY2017 | Feb 28, 2017 | $85.60M | Aug 4, 2017 |
| FY2017 | Nov 30, 2016 | $89.03M | Aug 4, 2017 |
| FY2017 | Aug 31, 2016 | $88.10M | Aug 4, 2017 |
| FY2017 | May 31, 2016 | $93.42M | Aug 4, 2017 |
| FY2017 | Feb 29, 2016 | $87.43M | Aug 4, 2017 |
| FY2017 | Nov 30, 2015 | $89.28M | Aug 4, 2017 |
| FY2017 | Aug 31, 2015 | $83.75M | Aug 4, 2017 |
| FY2016 | May 31, 2015 | $90.70M | Aug 1, 2016 |
| FY2016 | Feb 28, 2015 | $86.60M | Aug 1, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $157.71M | Jul 18, 2025 |
| FY2025 | May 31, 2024 | $154.70M | Jul 18, 2025 |
| FY2025 | May 31, 2023 | $174.25M | Jul 18, 2025 |
| FY2024 | May 31, 2022 | $165.73M | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $156.79M | Aug 3, 2023 |
| FY2020 | May 31, 2020 | $30.21M | Aug 10, 2020 |
| FY2020 | Feb 29, 2020 | $40.30M | Aug 10, 2020 |
| FY2020 | Nov 30, 2019 | $41.54M | Aug 10, 2020 |
| FY2020 | Aug 31, 2019 | $38.22M | Aug 10, 2020 |
| FY2020 | May 31, 2019 | $41.33M | Aug 10, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($33.99M) | Jul 18, 2025 |
| FY2025 | May 31, 2024 | ($184.35M) | Jul 18, 2025 |
| FY2025 | May 31, 2023 | ($52.44M) | Jul 18, 2025 |
| FY2024 | May 31, 2022 | ($26.55M) | Jul 25, 2024 |
| FY2023 | May 31, 2021 | ($31.55M) | Aug 3, 2023 |
| FY2020 | May 31, 2020 | ($157.07M) | Aug 10, 2020 |
| FY2020 | Feb 29, 2020 | ($5.71M) | Aug 10, 2020 |
| FY2020 | Nov 30, 2019 | ($2.74M) | Aug 10, 2020 |
| FY2020 | Aug 31, 2019 | ($1.28M) | Aug 10, 2020 |
| FY2020 | May 31, 2019 | $58.87M | Aug 10, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($39.95M) | Jul 18, 2025 |
| FY2025 | May 31, 2024 | ($192.44M) | Jul 18, 2025 |
| FY2025 | May 31, 2023 | ($51.18M) | Jul 18, 2025 |
| FY2024 | May 31, 2022 | ($28.47M) | Jul 25, 2024 |
| FY2023 | May 31, 2021 | ($35.28M) | Aug 3, 2023 |
| FY2022 | May 31, 2020 | ($167.10M) | Jul 22, 2022 |
| FY2021 | May 31, 2019 | ($9.40M) | Jul 27, 2021 |
| FY2020 | May 31, 2018 | ($14.17M) | Aug 10, 2020 |
| FY2019 | May 31, 2017 | ($11.18M) | Jul 25, 2019 |
| FY2018 | May 31, 2016 | $1.02M | Jul 23, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $26.22M | Jul 18, 2025 |
| FY2025 | May 31, 2024 | $31.51M | Jul 18, 2025 |
| FY2025 | May 31, 2023 | $29.88M | Jul 18, 2025 |
| FY2024 | May 31, 2022 | $30.74M | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $36.39M | Aug 3, 2023 |
| FY2022 | May 31, 2020 | $29.68M | Jul 22, 2022 |
| FY2021 | May 31, 2019 | $28.26M | Jul 27, 2021 |
| FY2020 | May 31, 2018 | $24.34M | Aug 10, 2020 |
| FY2019 | May 31, 2017 | $24.15M | Jul 25, 2019 |
| FY2018 | May 31, 2016 | $25.05M | Jul 23, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($10.13M) | Jul 18, 2025 |
| FY2025 | May 31, 2024 | ($28.16M) | Jul 18, 2025 |
| FY2025 | May 31, 2023 | $78.0K | Jul 18, 2025 |
| FY2024 | May 31, 2022 | ($7.19M) | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $24.09M | Aug 3, 2023 |
| FY2022 | May 31, 2020 | ($14.55M) | Jul 22, 2022 |
| FY2021 | May 31, 2019 | $37.44M | Jul 27, 2021 |
| FY2020 | May 31, 2018 | $41.29M | Aug 10, 2020 |
| FY2019 | May 31, 2017 | $55.75M | Jul 25, 2019 |
| FY2018 | May 31, 2016 | $45.22M | Jul 23, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $4.46M | Jul 18, 2025 |
| FY2025 | May 31, 2024 | $2.52M | Jul 18, 2025 |
| FY2025 | May 31, 2023 | $3.81M | Jul 18, 2025 |
| FY2024 | May 31, 2022 | $4.30M | Jul 25, 2024 |
| FY2023 | May 31, 2021 | $5.19M | Aug 3, 2023 |
| FY2022 | May 31, 2020 | $7.24M | Jul 22, 2022 |
| FY2021 | May 31, 2019 | $3.12M | Jul 27, 2021 |
| FY2020 | May 31, 2018 | $2.39M | Aug 10, 2020 |
| FY2019 | May 31, 2017 | $3.00M | Jul 25, 2019 |
| FY2018 | May 31, 2016 | $2.33M | Jul 23, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $280.14M | Jul 18, 2025 |
| FY2025 | May 31, 2024 | $317.67M | Jul 18, 2025 |
| FY2024 | May 31, 2023 | $532.64M | Jul 25, 2024 |
| FY2023 | May 31, 2022 | $552.75M | Aug 3, 2023 |
| FY2022 | May 31, 2021 | $561.44M | Jul 22, 2022 |
| FY2021 | May 31, 2020 | $594.21M | Jul 27, 2021 |
| FY2020 | May 31, 2019 | $836.44M | Aug 10, 2020 |
| FY2019 | May 31, 2018 | $705.47M | Jul 25, 2019 |
| FY2018 | May 31, 2017 | $707.96M | Jul 23, 2018 |
| FY2017 | May 31, 2016 | $726.19M | Aug 4, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $97.17M | Jul 18, 2025 |
| FY2025 | May 31, 2024 | $112.09M | Jul 18, 2025 |
| FY2024 | May 31, 2023 | $154.34M | Jul 25, 2024 |
| FY2023 | May 31, 2022 | $128.26M | Aug 3, 2023 |
| FY2022 | May 31, 2021 | $121.98M | Jul 22, 2022 |
| FY2021 | May 31, 2020 | $139.34M | Jul 27, 2021 |
| FY2020 | May 31, 2019 | $221.62M | Aug 10, 2020 |
| FY2019 | May 31, 2018 | $162.88M | Jul 25, 2019 |
| FY2018 | May 31, 2017 | $192.93M | Jul 23, 2018 |
| FY2017 | May 31, 2016 | $218.97M | Aug 4, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $182.97M | Jul 18, 2025 |
| FY2025 | May 31, 2024 | $205.59M | Jul 18, 2025 |
| FY2025 | May 31, 2023 | $378.30M | Jul 18, 2025 |
| FY2025 | May 31, 2022 | $424.49M | Jul 18, 2025 |
| FY2024 | May 31, 2021 | $439.46M | Jul 25, 2024 |
| FY2023 | May 31, 2020 | $454.87M | Aug 3, 2023 |
| FY2022 | May 31, 2019 | $614.82M | Jul 22, 2022 |
| FY2021 | May 31, 2018 | $542.60M | Jul 27, 2021 |
| FY2020 | May 31, 2017 | $515.03M | Aug 10, 2020 |
| FY2019 | May 31, 2016 | $507.23M | Jul 25, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | May 31, 2024 | $0 | Jul 25, 2024 |
| FY2024 | May 31, 2023 | $159.24M | Jul 25, 2024 |
| FY2024 | May 31, 2022 | $201.06M | Jul 25, 2024 |
| FY2022 | May 31, 2021 | $201.32M | Jul 22, 2022 |
| FY2021 | May 31, 2020 | $200.52M | Jul 27, 2021 |
| FY2020 | May 31, 2019 | $347.67M | Aug 10, 2020 |
| FY2019 | May 31, 2018 | $285.94M | Jul 25, 2019 |
| FY2019 | May 30, 2018 | $361.25M | Jul 25, 2019 |
| FY2018 | May 31, 2017 | $361.25M | Jul 23, 2018 |
| FY2017 | May 31, 2016 | $361.25M | Aug 4, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | ($429.20M) | Jul 18, 2025 |
| FY2025 | May 31, 2024 | ($395.20M) | Jul 18, 2025 |
| FY2024 | May 31, 2023 | ($210.86M) | Jul 25, 2024 |
| FY2023 | May 31, 2022 | ($158.41M) | Aug 3, 2023 |
| FY2022 | May 31, 2021 | ($131.87M) | Jul 22, 2022 |
| FY2021 | May 31, 2020 | ($100.32M) | Jul 27, 2021 |
| FY2020 | May 31, 2019 | $66.47M | Aug 10, 2020 |
| FY2019 | May 31, 2018 | $5.13M | Jul 25, 2019 |
| FY2018 | May 31, 2017 | ($11.01M) | Jul 23, 2018 |
| FY2017 | May 31, 2016 | ($16.02M) | Aug 4, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $55.89M | Jul 18, 2025 |
| FY2025 | May 31, 2024 | $76.06M | Jul 18, 2025 |
| FY2024 | May 31, 2023 | $44.62M | Jul 25, 2024 |
| FY2023 | May 31, 2022 | $28.83M | Aug 3, 2023 |
| FY2022 | May 31, 2021 | $48.16M | Jul 22, 2022 |
| FY2021 | May 31, 2020 | $54.44M | Jul 27, 2021 |
| FY2020 | May 31, 2019 | $227.64M | Aug 10, 2020 |
| FY2019 | May 31, 2018 | $74.10M | Jul 25, 2019 |
| FY2019 | May 31, 2017 | $47.54M | Jul 25, 2019 |
| FY2019 | May 31, 2016 | $32.33M | Jul 25, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | May 31, 2024 | $0 | Jul 25, 2024 |
| FY2024 | May 31, 2023 | $49.82M | Jul 25, 2024 |
| FY2023 | May 31, 2022 | $25.00M | Aug 3, 2023 |
| FY2019 | May 31, 2019 | $131.91M | Jul 25, 2019 |
| FY2018 | May 31, 2018 | $91.62M | Jul 23, 2018 |
| FY2017 | May 31, 2017 | $96.32M | Aug 4, 2017 |
| FY2014 | May 31, 2014 | $142.66M | Jan 12, 2015 |
| FY2014 | May 31, 2013 | $142.50M | Jan 12, 2015 |
| FY2013 | May 31, 2012 | $150.00M | Aug 14, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 0 | Jul 18, 2025 |
| FY2025 | May 31, 2024 | (4) | Jul 18, 2025 |
| FY2025 | May 31, 2023 | (1) | Jul 18, 2025 |
| FY2024 | May 31, 2022 | 0 | Jul 25, 2024 |
| FY2023 | May 31, 2021 | 0 | Aug 3, 2023 |
| FY2020 | May 31, 2020 | (4) | Aug 10, 2020 |
| FY2020 | Feb 29, 2020 | 0 | Aug 10, 2020 |
| FY2020 | Nov 30, 2019 | 0 | Aug 10, 2020 |
| FY2020 | Aug 31, 2019 | 0 | Aug 10, 2020 |
| FY2020 | May 31, 2019 | 1 | Aug 10, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 0 | Jul 18, 2025 |
| FY2025 | May 31, 2024 | (4) | Jul 18, 2025 |
| FY2025 | May 31, 2023 | (1) | Jul 18, 2025 |
| FY2024 | May 31, 2022 | 0 | Jul 25, 2024 |
| FY2023 | May 31, 2021 | 0 | Aug 3, 2023 |
| FY2020 | May 31, 2020 | (4) | Aug 10, 2020 |
| FY2020 | Feb 29, 2020 | 0 | Aug 10, 2020 |
| FY2020 | Nov 30, 2019 | 0 | Aug 10, 2020 |
| FY2020 | Aug 31, 2019 | 0 | Aug 10, 2020 |
| FY2020 | May 31, 2019 | 1 | Aug 10, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 40.99M | Jul 18, 2025 |
| FY2025 | May 31, 2024 | 40.43M | Jul 18, 2025 |
| FY2024 | May 31, 2023 | 39.61M | Jul 25, 2024 |
| FY2023 | May 31, 2022 | 39.17M | Aug 3, 2023 |
| FY2022 | May 31, 2021 | 38.55M | Jul 22, 2022 |
| FY2021 | May 31, 2020 | 38.08M | Jul 27, 2021 |
| FY2020 | May 31, 2019 | 37.61M | Aug 10, 2020 |
| FY2019 | May 31, 2018 | 37.22M | Jul 25, 2019 |
| FY2018 | May 31, 2017 | 36.84M | Jul 23, 2018 |
| FY2017 | May 31, 2016 | 36.28M | Aug 4, 2017 |